Latest Registration Statement Stories

SAN DIEGO, April 4, 2013 /PRNewswire/ -- Receptos, Inc., a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by Receptos. The number of...

HOUSTON, April 4, 2013 /PRNewswire/ -- Goodrich Petroleum Corporation (NYSE: GDP) (the "Company") today announced the pricing of its public offering of $100 million of non-convertible, perpetual preferred stock through the issuance of 4,000,000 depositary shares each representing a 1/1000th ownership interest in a share of the Company's non-convertible 10.00% Series C Cumulative Preferred Stock. In connection with the offering, the Company granted the underwriters a 30-day option...

HOUSTON, April 4, 2013 /PRNewswire/ -- Goodrich Petroleum Corporation (NYSE: GDP) (the "Company") today announced that it has commenced, subject to market and other conditions, an underwritten public offering of non-convertible, perpetual preferred stock through the issuance of depositary shares each representing a 1/1000th ownership interest in a share of the Company's Series C Cumulative Preferred Stock. In connection with the offering, the Company intends to grant the underwriters...

SAN FRANCISCO, April 2, 2013 /PRNewswire/ -- Digital Realty Trust, Inc. (the "Company" or "Digital Realty") (NYSE: DLR) today announced the pricing of an underwritten public offering of 9.0 million shares of 5.875% Series G Cumulative Redeemable Preferred Stock at a price of $25.00 per share for gross proceeds of $225.0 million. The offering is expected to close on April 9, 2013, subject to closing conditions. The Company has granted the underwriters a 30-day option to purchase up...

ATLANTA, March 25, 2013 /PRNewswire/ -- Graphic Packaging International, Inc. ("Graphic Packaging"), a wholly-owned subsidiary of Graphic Packaging Holding Company (NYSE: GPK), announced that it has entered into an agreement to sell $425 million aggregate principal amount of its senior unsecured notes due 2021 (the "Senior Notes") in a registered public offering. The Senior Notes will bear interest at an annual rate of 4.75% and will be issued at par. Graphic Packaging expects to...

ROCHESTER, N.Y., March 22, 2013 /PRNewswire/ -- Bausch + Lomb, the global eye health company, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC), through its holding company WP Prism, relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. (Logo:...

ATLANTA, March 21, 2013 /PRNewswire/ -- Graphic Packaging Holding Company (NYSE: GPK) today announced that the selling stockholders have increased the size of the previously announced underwritten secondary public offering of 25,000,000 shares of its common stock to 28,000,000 shares and priced the offering at $7.00 per share. The shares are being sold by certain existing stockholders of the Company. The Company is not selling any shares and will not receive any proceeds from the...

CHICAGO, March 20, 2013 /PRNewswire/ -- Aviv REIT, Inc. ("Aviv" or the "Company") announced today the pricing of its initial public offering of 13,200,000 shares of common stock at a public offering price of $20.00 per share. The shares are expected to begin trading March 21, 2013 on the New York Stock Exchange under the symbol "AVIV", and the offering is expected to close on March 26, 2013. The underwriters have the option to purchase up to an additional 1,980,000 shares of common...

Wednesday, March 20, 2013, 09:00:00 PM (GMT) GIVAT SHMUEL, Israel, March 20, 2013 /PRNewswire/ -- Cimatron Limited (NASDAQ and TASE: CIMT), a leading provider of integrated CAD/CAM software solutions for the toolmaking and manufacturing industries, today announced that certain of its shareholders are offering to sell ordinary shares of Cimatron in an underwritten public offering. Cimatron will not receive any of the proceeds from the offering of its ordinary shares by the...

KANSAS CITY, Kan. and BOSTON, March 20, 2013 /PRNewswire/ -- Aratana Therapeutics, Inc., a biopharmaceutical company focused on licensing, developing and commercializing innovative prescription medications for cats and dogs (companion animals), announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price...